Investors’ data
Latest news
- January 9, 2012
THALLION AND LFB COMPLETE PATIENT ENROLLMENT OF PHASE II SHIGATEC TRIAL
- October 24, 2011
BLINDED RESULTS FROM LOW DOSE COHORT OF PHASE II SHIGATEC TRIAL PRESENTED AT IDSA ANNUAL MEETING
- October 11, 2011
THALLION ANNOUNCES 2011 THIRD QUARTER RESULTS
Documentation
Corporate Governance
Thallion Pharmaceutical Inc. and its Board of Directors believe that transparent and sound corporate governance practices are critical to the Company’s long-term success.
The Board believes that the Company’s corporate governance practices are well aligned with the recommendations contained in the various applicable guidelines and regulations issued by the Toronto Stock Exchange (TSX Guidelines) and other securities regulators.
For further information, please refer to our corporate profile on SEDAR.